Scilex Holding Co (NASDAQ: SCLXW)

$0.14 0.00 (-0.14%)
As of Jun 03, 2026 04:00 PM
Sector: Healthcare Industry: Drug Manufacturers - General CIK: 0001820190
Total Debt (Qtr) 80.78 Mn
Revenue Growth (1y) (Qtr) 72.00
Add ratio to table...

About

Scilex Holding Co is an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain. The company markets three FDA approved products ZTlido for postherpetic neuralgia ELYXYB for acute migraine and GLOPERBA for gout prophylaxis. It also has a pipeline of product candidates including SEMDEXA for sciatica SP-103 for acute pain and SP-104 for fibromyalgia. Revenue is generated primarily from sales of its approved products ZTlido ELYXYB and...

Read more

Peer comparison

Companies in the Drug Manufacturers - General
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 GSK GSK plc 93,699,046.73 Bn 11.92 Mn 2.13 Mn -18.89 Bn
2 LLY ELI LILLY & Co 1,012.06 Bn 0.00 Mn 0.00 Mn 43.37 Bn
3 JNJ Johnson & Johnson 560.67 Bn 0.00 Mn 0.00 Mn 54.99 Bn
4 ABBV AbbVie Inc. 402.20 Bn 0.00 Mn 0.00 Mn 64.53 Bn
5 MRK Merck & Co., Inc. 298.59 Bn 0.00 Mn 0.00 Mn 49.12 Bn
6 AMGN Amgen Inc 188.77 Bn 0.00 Mn 0.00 Mn 57.32 Bn
7 GILD Gilead Sciences, Inc. 160.22 Bn 0.00 Mn 0.00 Mn 22.17 Bn
8 PFE Pfizer Inc 148.19 Bn 0.00 Mn 0.00 Mn 64.46 Bn